The FDA wants to reduce the nicotine content in cigarettes, among other things, reports Healio.

Among the items on the FDA’s to-do list:

  • Request public comment on the role that flavors, including menthol, in tobacco products play in drawing in youth and may play in helping some smokers switch to potentially less harmful forms of nicotine delivery;
  • Seek additional comments and scientific data related to the patterns of use and resulting public health impacts from premium cigars that were part of the FDA’s 2016 rule;
  • Enhance use and availability of FDA-approved medicinal nicotine products;
  • Work with stakeholders to come up with a strategy that’s within the efficacy and safety standards but can also assist smokers who want to quit; and
  • Establish rules that make the product review process more efficient, predictable and transparent for manufacturers, but still remain true to FDA’s mission.